Lacosamide Tablet, Film Coated
Product Images NDC 10135-802

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 10135-802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lac-12 (Lac 12)

This information presents Kaplan-Meier analysis of time to 2" PGTC seizure in Study 5. The figures include patients still at risk in the study at a specific timepoint, indicating those who have not experienced an event or been censored before that timepoint. Data analyzed from the Modified Full Analysis Set.*

FDA Label Image

Lacosamide-01 (Lacosamide 01)

FDA Label Image

Lacosamide-02 (Lacosamide 02)

FDA Label Image

Lacosamide-03 (Lacosamide 03)

FDA Label Image

Lacosamide-04 (Lacosamide 04)

FDA Label Image

Lacosamide-05 (Lacosamide 05)

This is a description for Lacosamide Tablets, USP. Each box contains 60 unit-dose tablets divided into 6 blister packs of 10 tablets each. The product is intended for individual use and specified for prescription only. The pharmacist is instructed to dispense the medication guide with each package provided to the patient.*

FDA Label Image

Lacosamide-06 (Lacosamide 06)

This is a description for Lacosamide Tablets, USP. The tablets come in a package containing 60 (6 x 10) unit-dose tablets. The text includes a specific serial number and instructions for pharmacists to dispense a medication guide to each patient.*

FDA Label Image

Lacosamide-07 (Lacosamide 07)

Lacosamide Tablets, USP 200 mg are available in blister pack unit-dose tablets of 6x10 tablets each. This prescription medication should only be dispensed with a Medication Guide to inform each patient about its usage. The NDC number for this product is 10135-802-86.*

FDA Label Image

Lacosamide-08 (Lacosamide 08)

This is a description for Lacosamide Tablets. Each tablet contains 50 mg of Lacosamide, USP. The usual dosage recommendations can be found in the package insert. These tablets should be stored at 20°C to 25°C (68-77°F) with excursions allowed between 15-30°C (59-86°F). The medication guide should be dispensed to each patient. The manufacturer is Medley Pharmaceuticals L. and it is manufactured for Kanchan Health Care Inc. Distributed by Marlex Pharmaceuticals Inc.*

FDA Label Image

Lacosamide-09 (Lacosamide 09)

The text provides information about a pharmaceutical product containing 100 mg of Lacosamide. It includes details on the distributor Marlex Pharmaceuticals, Inc., storage conditions, dosage information, and contact details for manufacturing and distribution. The tablets should be stored at temperatures between 15-30°C (59-86°F). Additionally, it instructs pharmacists to dispense a Medication Guide along with each prescription. Manufacturing information indicates that the product is manufactured by Kanchan Healthcare LLC in Parsippany, NJ, USA.*

FDA Label Image

Lacosamide-10 (Lacosamide 10)

This is a medication label for Lacosamide tablets, containing 150 mg of Lacosamide USP per tablet. The usual dosage instructions should be followed as per the package insert. The tablets should be stored at 20° to 26°C (68 to 77°F) with permissible excursions between 15-30°C (59-86°F). The medication is distributed by Miarlex Pharmaceuticals, Inc. in the USA. It includes manufacturing information for Medley Pharmaceuticals Ltd. in India and distribution details for Kanchan Healthcare Inc. in the USA.*

FDA Label Image

Lacosamide-11 (Lacosamide 11)

This text provides information about lacosamide tablets containing 200 mg of the active ingredient. It includes instructions for dispensing a Medication Guide to each patient, storage conditions, dosage information, and manufacturer details. The product is distributed by Marlex Pharmaceuticals in the USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.